Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Waterloo

$41,000.00

The role of endogenous lipids in the regulation of insulin exocytosis

EF 2024-25

Résumé
Pancreatic ß-cells play an essential role in regulating energy homeostasis. ß-cells release insulin in response to elevated nutrient levels of glucose, amino acids, & lipids. How ß-cells respond to respond to rising lipid levels is incompletely understood. There are three sources of free fatty acids (FFA) 1) exogenously derived FFAs, 2) endogenously synthesized FFAs (de novo lipogenesis (DNL)), & 3) release from internal triglyceride stores. DNL occurs primarily in liver cells; however, many tissue types can produce limited amounts of lipids. The role of this small amount of DNL in these cell types is not entirely understood. For example, ß-cells express enzymes that lead to DNL in proportion to the amount of glucose exposure. This glucose-driven DNL has been proposed to be important in generating metabolic signaling molecules critical for regulating insulin exocytosis. In addition, it has been suggested that glycerolipid / nonesterified fatty acids cycling from internal triglyceride stores may also regulate insulin release. Inhibition of this cycling suppresses FFA augmentation of glucose-stimulated insulin release. Our laboratory has published results showing the effects of manipulating four key enzymes (PC, CL, ACC, and FAS) and three metabolic carriers (pyruvate carrier, citrate carrier, and dicarboxylate carrier) that are involved in DNL support the role of DNL in regulating insulin exocytosis. Most lipid metabolism pathways involved in regulating insulin secretion require lipids to be activated by acyl CoA synthetases (ACSL); however, we know very little about how this happens. In addition, it has been suggested that different lipid metabolism pathways are controlled by the unique subcellular localization of different isoforms of ACSL proteins. We will investigate the role of lipids in regulating glucose-stimulated insulin release with a focus on the subcellular localization of ACSL proteins and how lipid activation affects metabolism and insulin release. There are two objectives to the proposed studies. Objective 1) will assess the subcellular localization of lipid-activating enzymes (ACSL1, 3-6) in clonal and primary insulin-secreting cells. Objective 2) will investigate the metabolic consequences of how the subcellular localization of ACSLs controls lipid metabolism and regulates insulin release. Hypothesis: Subcellular localization of ACSL controls the entry of activated lipids into downstream metabolic pathways and plays a role in the regulation of insulin secretion from ß-cells. Novelty & significance: It is well known that lipids regulate insulin secretion. However, what role, if any, of the subcellular localization of ACSL proteins and the downstream lipid metabolism plays in insulin secretion is unknown. The role of lipids in the regulation of insulin release will be assessed in our NSERC application. HQP trained in our laboratory will learn state-of-the-art techniques that are highly sought after in academia and industry.
Programme
Discovery Grants Program - Individual
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2024-03762
Name nom
Joseph, Jamie
Department département
Pharmacy, School of - Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5107
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell secretion
Research subject fr
Sécrétions cellulaires
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
The role of endogenous lipids in the regulation of insulin exocytosis
Keywords
metabolomics; lipids; insulin; pancreas; beta cells; lipogenesis; exocytosis; signaling molecules; metabolism; islets
Application summary
Pancreatic ß-cells play an essential role in regulating energy homeostasis. ß-cells release insulin in response to elevated nutrient levels of glucose, amino acids, & lipids. How ß-cells respond to respond to rising lipid levels is incompletely understood. There are three sources of free fatty acids (FFA) 1) exogenously derived FFAs, 2) endogenously synthesized FFAs (de novo lipogenesis (DNL)), & 3) release from internal triglyceride stores. DNL occurs primarily in liver cells; however, many tissue types can produce limited amounts of lipids. The role of this small amount of DNL in these cell types is not entirely understood. For example, ß-cells express enzymes that lead to DNL in proportion to the amount of glucose exposure. This glucose-driven DNL has been proposed to be important in generating metabolic signaling molecules critical for regulating insulin exocytosis. In addition, it has been suggested that glycerolipid / nonesterified fatty acids cycling from internal triglyceride stores may also regulate insulin release. Inhibition of this cycling suppresses FFA augmentation of glucose-stimulated insulin release. Our laboratory has published results showing the effects of manipulating four key enzymes (PC, CL, ACC, and FAS) and three metabolic carriers (pyruvate carrier, citrate carrier, and dicarboxylate carrier) that are involved in DNL support the role of DNL in regulating insulin exocytosis. Most lipid metabolism pathways involved in regulating insulin secretion require lipids to be activated by acyl CoA synthetases (ACSL); however, we know very little about how this happens. In addition, it has been suggested that different lipid metabolism pathways are controlled by the unique subcellular localization of different isoforms of ACSL proteins. We will investigate the role of lipids in regulating glucose-stimulated insulin release with a focus on the subcellular localization of ACSL proteins and how lipid activation affects metabolism and insulin release. There are two objectives to the proposed studies. Objective 1) will assess the subcellular localization of lipid-activating enzymes (ACSL1, 3-6) in clonal and primary insulin-secreting cells. Objective 2) will investigate the metabolic consequences of how the subcellular localization of ACSLs controls lipid metabolism and regulates insulin release. Hypothesis: Subcellular localization of ACSL controls the entry of activated lipids into downstream metabolic pathways and plays a role in the regulation of insulin secretion from ß-cells. Novelty & significance: It is well known that lipids regulate insulin secretion. However, what role, if any, of the subcellular localization of ACSL proteins and the downstream lipid metabolism plays in insulin secretion is unknown. The role of lipids in the regulation of insulin release will be assessed in our NSERC application. HQP trained in our laboratory will learn state-of-the-art techniques that are highly sought after in academia and industry.